718.13MMarket Cap
LossP/E TTM
Astria Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-01-22The current valuation score of Astria Therapeutics Inc is 6.17, ranking 323 out of 395 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.88, which is -66.05% below the recent high of -2.00 and -17.28% above the recent low of -6.90.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.